Since its isolation in 1911 by Peyton Rous (50), Rous sarcoma virus (RSV) has been an extremely important system for virus oncologists. RSV induces morphological transformation of chicken embryo fibroblasts in vitro (24) and causes fibrosarcomas after injection of chickens. The ability of RSV to induce tumors and morphological transformation has been correlated with the presence of the src gene (24, 68) . The src gene encodes a tyrosine-specific protein kinase with a molecular weight of 60,000 (10, 11, 16, 36) .
The ability of RSV to induce tumors in mammals and to cause transformation of mammalian cells has been extensively studied. Tumor formation generally occurs only after a long latency (57, 67, 74) . The ability of different strains to induce tumor formation seems to correlate with the subgroup of the envelope glycoproteins of these strains rather than to intrinsic differences in the src genes of these isolates (8, 72) . Furthermore, it is extremely difficult to recover infectious RSV directly from mammalian tumor material (1-3, 61, 62, 73) or from transformed mammalian cells (20, 56, 63 mammalian cells with chicken cells (56, 59, 63) . The inability to rescue infectious virus is probably due to the fact that not all the viral genes are transcribed in RSV-transformed mammalian cells and that the level of viral RNA is reduced compared with that in virus-infected chicken cells (7, 12, 66) . Furthermore, there seems to be a block in the processing of at least the gag proteins in nonavian cells (69) .
With the advent of molecular cloning of retroviral genomes, it has become possible to construct recombinant viruses containing a variety of sequences, such as the thymidine kinase gene of herpes simplex virus (55, 64, 71) . We have sought to construct a replication-defective transforming murine retrovirus which contains the src gene of RSV. Such a recombinant murine retrovirus would be of great interest to tumor virologists since it would be readily able to infect (and transform) the cells present in a wide variety of mammalian systems currently available to biologists. We report here the isolation of such a recombinant virus and note the difference between src-containing murine retroviruses and avian RSV.
MATERIALS AND METHODS Cells. NIH 3T3 cells, a line of NIH 3T3 cells transformed by the Schmidt-Ruppin strain of RSV, a line of NRK cells nonproductively infected by the Friend spleen focus-forming virus, and a line of NIH 3T3 cells nonproductively transformed by Harvey murine sarcoma virus were obtained from the stocks of this laboratory as previously described (21, 39, 40, 51) . They were all grown in Dulbecco modified Eagle medium supplemented with 10% fetal calf serum.
DNA transfections. DNA transfections were performed by a modification of the method of Graham and van der Eb (22) as previously described (39, 40, 71) . Briefly, 3 x 105 NIH 3T3 cells were seeded into 35 (15) . Colonies were screened by the method of Grunstein and Hogness (23) . The filters were baked for 2 h at 80°C in vacuo and hybridized to an src-specific probe. Hybridization was carried out at 42°C in 50% formamide, 5x SSC (1x SSC = 0.15 M NaCl plus 0.015 M sodium citrate), and 0.1% sodium dodecyl sulfate (SDS). src-containing colonies were amplified and examined for the presence of src and amphotropic murine leukemia virus (MuLV) DNA sequences, and the arrangement of these sequences was determined. All DNA probes were prepared by nick translation (38) . DNA blotting from 1.0% agarose gels to nitrocellulose filters (Schleicher & Schuell Co.) was performed by the technique of Southern (60) . Hybridizations were performed as described above. All enzymes were obtained from Bethesda Research Laboratories, Inc.
Metabolic labeling of cells, immunoprecipitation, and SDS-gel electrophoresis. Labeling of cells was done as previously described (6) (34) . Gels were treated with En3Hance (New England Nuclear), dried, and exposed to X-ray film at -70°C.
Immune complex protein kinase assay. The immune complex protein kinase assay was performed as described previously (6) . The reaction buffer consisted of 60 (3, 000 Ci/mmol; Amersham Corp.). The reaction products were analyzed on 7.5% SDS-polyacrylamide gels.
Antiserum. Tumor-bearing rabbit serum was the gift of H. Opperman, University of California, San Francisco, Calif., and H. Hanafusa, Rockefeller University, New York. These sera recognize pp60src and a few structural proteins characteristic of avian retroviruses (10) . Antisera specific for MuLV p15, Rauscher MuLV gp7O, and the gp7O of mink cell focus-forming viruses (MCFs) were provided by S. Ruscetti, National Cancer Institute, Bethesda, Md. M. Furth, National Cancer Institute, kindly provided monoclonal 259, which recognizes p21 of Harvey and Kristen sarcoma viruses (21) . Rabbit anti-avian leukosis virus gag and env serum was produced as described previously (6) .
Mice. Six-week-old female NIH Swiss mice were obtained from the National Institutes of Health, Bethesda, Md.
RESULTS
Construction of clones containing src and amphotropic viral sequences. The DNAs used in this study are shown in Fig. 1 . The amphotropic virus 4070A was molecularly cloned in pBR322 at the EcoRI site within the env gene, and this clone, AMT8, contains a single long terminal repeat (LTR). The src gene was present in a 3-kb EcoRI fragment derived from the molecular clone of SRA-RSV (17) . In addition to the src coding region, this DNA includes the coding region of SRA-RSV gp37, the direct repeats which flank the src gene, and the U3 region of the LTR (17, 71a fected cells and cloned in soft agar. Colonies of transformed cells were picked after 10 to 14 days. The supernatant fluids from such clones were screened by the polymerase assay for the presence of virus particles and by infection of fresh NIH 3T3 cells for the production of infectious transforming virus. A number of clones were isolated which did not produce infectious transforming virus. Some of these clones, such as 2-1 and 18-31, produced noninfectious, polymerase-positive virus particles (Table 1) , indicating that the virus present in these cells contains both functional gag and pol genes, analogous to cells transformed by the Bryan strain of RSV (18, 26, 48) . The Bryan strain of RSV contains functional gag and pol genes but not a functional env gene, resulting in the production of a noninfectious, polymerase-positive virus particle. In this paper, we refer to both types of clones, those which produce noninfectious, polymerase-positive particles and those that do not, as nonproducer cells, since they do not produce biologically active transforming virus. Clone numbers with a prefix of 2 were derived from virus produced by transfection of cells with DNA clone 63-2 plus EcoRI-cut AMT8 DNA, whereas those with a prefix of 18 were derived from virus produced by transfection of cells with unligated EcoRI-cut pSRC2 and EcoRI-cut AMT8 DNAs. Infectious transforming virus could be recovered by superinfect- Fig. 2 . The only virus-related proteins found in all clones were Pr659'9, the precursor to the gag proteins (Fig. 2, lanes B and G) ; Prl8ygag-Pol the precursor to the enzyme reverse transcriptase (Fig. 2, lanes B and G) ; and pp6OSrc (Fig. 2 , lanes E and J). The presence of Pr18gWag-Po, is also confirmed by the fact that these two clones both produce noninfectious, polymerase-positive virus particles (see above and Table 1 ).
The pp6O,rc protein of the recombinant viruses comigrated with authentic pp6OSrc from NIH 3T3 cells transformed by the Schmidt-Ruppin D strain of RSV (data not shown). No MuLV gp7O was observed in any of the nonproducer cell lines (Fig. 2, lanes C and H) . A protein of approximately 32,000 daltons is shown in Fig. 2 , lanes C and H; however, this protein was not observed in all nonproducer clones, and its appearance did not relate to any detectable biological properties of the viruses produced by (52) . The producer clones were infected with the amphotropic virus 4070A in addition to the src recombinant viral genome.
clones observed to contain this protein. The theoretical molecular weight of the truncated env gene product would be approximately 21,000, on the basis of the sequence data from Moloney MCF (9) and RSV strain Prague A (71a) (see below). Therefore, the observed 32,000-dalton protein is significantly larger than would be expected for the truncated env protein.
In addition, no proteins related to the avian retrovirus gag or env gene products were observed (Fig. 2, lanes D and I) . The 35,000-dalton protein seen in the immunoprecipitates prepared with anti-MuLV p15 serum (Fig. 2, lanes B and  G) is probably an intermediate in the processing of the gag gene product. A protein of 65,000 daltons is immunoprecipitated by the serum which recognizes the avian leukosis virus gag and env gene products (Fig. 2, lanes D and I) .
We do not believe that this is a gene product encoded by the avian retroviral gag gene, because we have seen it in NIH 3T3 cells which do not contain the src recombinant viral genome (data not shown). The only viral proteins consistently observed in all nonproducer clones were Pr5gag, Pr1809"'g9Pll, and pp60sr.
Kinase activity of the src protein from the recombinant virus. The pp60sr' protein of RSV is active as a protein kinase in the immune complex protein kinase assay (16, 36) . We sought to demonstrate that this activity of the src (Fig. 3, lane B) is indicative of the normal cellular levels of c-src in these cells. The kinase activity present in the cells transformed by the src recombinant was always higher than those observed in uninfected NIH 3T3 cells (Fig. 3 els of pp60src in clone 18-17 were equivalent to those seen in any other nonproducer cell clone when measured by incorporation of [35S]methionine into pp6src. Thus, it is apparent that the pp6Osrc encoded by the recombinant murine retrovirus is still active as a protein kinase and that this activity has not been altered by the manipulations involved in cloning this sequence into a new virus vector. It is interesting to note that we did not observe autophosphorylation of pp6Osrc in the kinase assay, even when two different preparations of tumor-bearing rabbit serum were used. Autophosphorylation has been described as being an inherent property of pp6Osrc (47) .
Biological activity of the src recombinant virus. The biological activity of the src recombinant virus was analyzed by injecting 6-week-old female NIH Swiss mice with either F-MuLV or Mo-MuLV pseudotypes of the src recombinant virus prepared by superinfecting nonproducer cells with these helper viruses. Mice were injected intramuscularly with 0.2 ml of tissue culture fluids or intravenously with 0.5 ml of tissue culture fluids. The virus titers used for injection varied from 3 X 103 to 4 x 105 focus-forming units for the intramuscular injection to 7.5 x 103 to 1 x 106 focus-forming units for the intravenous injection. Mice injected intramuscularly were observed for sarcoma formation. To date, no sarcomas have been observed at the site of injection in any of the animals receiving the transforming virus by means of intramuscular injection; over 100 animals have been examined with F-MuLV and Mo-MuLV pseudotypes of eight independent clones of the virus (clones 2-1, 2-3, 2-14, 2-25, 18-7, 18-8, 18-17, and 18-25) and the amphotropic pseudotypes of the recombinant virus generated from the original transfect- In contrast to the absence of tumors after intramuscular injection, intravenous injection of mice gave rise to splenic foci after 2 weeks and pronounced splenomegaly after 4 to 8 weeks. The spleens from mice infected with Mo-MuLV pseudotypes of three independent isolates of the src recombinant virus are shown in Fig. 4 , along with the spleens from Mo-MuLV-infected control animals and uninfected control animals. Splenomegaly was apparent by 6 to 8 weeks. The increased spleen size could clearly be seen by 8 weeks postinfection (Fig. 4) . Splenic foci were clearly observable by 2 weeks (Fig. 5) . The foci present on the spleens of mice infected with the src recombinant virus are similar to those seen after infection of mice with either Harvey 46, 1983 ."- or Kirsten sarcoma viruses. These foci are somewhat larger than those seen with the polycythemic strain of Friend spleen focus-forming virus, and they also have less distinct boundaries. Table 2 shows data on mice infected with MoMuLV pseudotypes of eight independent clones of src recombinant viruses. Two animals were examined at each time point, and Table 2 shows spleen weight, hematocrit levels, and the presence of splenic foci. The degree of splenomegaly varied from isolate to isolate, perhaps owing to variation in the input titer of the virus used in each infection. By 8 weeks after infection, the hematocrit levels of some animals began to fall, and by 10 weeks after infection, anemia was observed in nearly all animals with splenomegaly. Whether the anemia was a direct effect of the virus or related to the spenomegaly could not be determined. It is apparent, however, that polycythemia is not induced in these animals, as is seen with some strains of spleen focus-forming virus. Similar results were obtained with virus stocks obtained from eight independent nonproducer clones (2-1, 2-3, 2-14, 2-25, 18-7, 18-8, 18-17, and 18-22). As noted above, these clones vary in their abilities to produce noninfectious, polymerase-positive particles, and thus this genetic difference plays no role in the induction of the disease observed.
The spleens of mice infected with the src recombinant virus contain primarily cells of the erythroid lineage, as determined by touch prints prepared from these spleens and by examination of cytospin preparations of cell suspensions prepared from these spleens (data not shown (Fig. 6 ) indicate that only pp60src was present in elevated levels in the transformed cells as compared with cells infected with extracts from control animals. No gp52, the transforming protein of Friend spleen focusforming virus (19, 37, 51) , or proteins related to MCF gp7O were observed after immunoprecipitation with an antiserum specific for MCF gp7O (Fig. 6, lanes B and F) . The gp7O of the helper virus F-MuLV was not observed because anti- Harvey and Kirsten sarcoma viruses, which encode p21ras (54) , are able to induce erythroleukemia in mice (53) . Therefore, the level of p2lras in cells transformed by the recovered virus was examined to exclude the possibility that a virus encoding p21 had been rescued. p2lras was present in both transformed cells and normal control cells (Fig. 6, lanes C and G) . Although there appears to be a slight increase in the amount of p2lras in lane G versus lane C, we do not believe that this increase is significant enough to indicate that a p21-encoding virus is responsible for the observed disease. Furthermore, this difference was not observed in other experiments in which we have recovered virus from the tissues of infected animals. Further experiments are in progress to eliminate the possibility that a ras-containing virus is involved in the observed disease. Only the level of pp6Osrc was vastly increased in transformed cells as compared with the control cells (Fig. 6 ), lane D versus lane H). These results indicate that a transforming virus encoding pp6Osrc can be recovered from the spleens of diseased animals. Viruses encoding p21 or MCF-related glycoproteins, including gp52 of spleen focus-forming virus, were not recovered from these spleens. The observed erythroleukemia thus does not involve the ras gene of either Harvey or Kirsten sarcoma viruses, two viruses which can induce erythroleukemia in mice (53) . In addition, our inability to observe either gp52 of spleen focusforming virus or MCF-related gp70 rules out the involvement of these types of viruses in the disease studied here. Spleen focus-forming virus is responsible for the rapid erythroleukemia induced by the Friend virus complex (65) . MCF viruses may play a role in the induction of anemia by F-MuLV and are found in erythroid cell lines established from such animals (41).
We have not been able to directly immunoprecipitate pp6Osrc from [35S]methionine-labeled spleen cells from diseased animals. We assume that the levels of pp60src are not high enough or the background of labeled cellular proteins is too high to permit its observation. Unfortunately, the anti-pp60src serum available to us apparently does not recognize denatured pp6Osrc, and therefore, we are not able to detect pp60src by "Western transfer" of proteins to nitrocellulose filters and binding of antibody to these filters.
DISCUSSION
We report here the isolation of a murine transforming virus containing the src gene of SRA-RSV. The src gene was inserted into the env region of the replication-competent virus amphotropic MuLV 4070A, thus generating a replication-defective transforming virus. The EcoRI site present in the env region of MCF and amphotropic MuLVs is highly conserved (13) . A comparison of the reading frames and sequences surrounding this EcoRI site in the env gene of Moloney MCF (9) and the env gene of RSV Prague C (71a) indicates that this fusion results in a 1 + change in the reading frame of the RSV env gene, resulting in a termination codon 12 bases after the EcoRI site. Therefore, the fusion Ampho MuLV env-RSV env gene product contains 191 amino acids and has a theoretical molecular weight of 21,000 daltons. The only protein observed with the anti-MuLV gp70 protein is considerably larger (32,000 daltons) and may not be present in every clone examined. Thus, none of the src-containing recombinant viruses contain functional env gene products. At least some virus isolates, however, contained both functional gag and pol genes. The src gene of these recombinant viruses encoded a pp6osrc protein of approximately the same size as that of the Schmidt-Ruppin strain of RSV. This protein was active in the immune complex protein kinase assay.
Biologically active transforming virus was isolated only from cells receiving constructions in which the src gene was present in the same polarity as that of the viral genome containing the src gene insert. This is presumably because proper splicing of the src gene coding sequences to the viral leader sequences containing the promoter elements must occur for expression of the src gene. The interaction of RSV with mammalian cells in vivo and in vitro has been extensively studied (1, 56, 57, 61, 73, 74) . In most cases, sarcomas can be induced either by transplantation of chicken sarcoma material or, in a few studies, with cell-free preparations from tumors. The efficiency of tumor induction varies with the RSV strain used, the type and age of the animals, and route of inoculation. The recovery of infectious RSV from mammalian tumors or cells transformed in vitro is rare (5, 33, 58, 62) . It is possible, however, to recover infectious RSV by cocultivation of mammalian cells with chicken embryo fibroblasts (56, 59, 63) . Inoculation of newborn mice with minced tumor tissue gives rise to tumors in approximately 25% of the animals. (1, 4) . Ahlstrom (1) noted that no tumors were observed in mice older than 10 days at the time of injection. Jonsson (30) observed sarcoma induction after injection of mice with cell-free preparations from chicken sarcomas. These tumors could be maintained by transplantation to other mice, and sarcomas could be induced in chickens with minced tumor tissue. Transfer of the sarcoma to either other mice or chickens could not be performed with cell-free extracts from the mouse sarcoma, indicating that there was no infectious transforming virus produced by these cells.
Our results differ from those of previous studies in two ways. First, we are readily able to recover infectious transforming virus from both cells transformed in vitro and tissues from diseased animals. Second, the disease spectrum we observed varies significantly. We primarily observed an erythroproliferative disease characterized by splenomegaly and anemia. We are studying the response of newborn mice to the src recombinant virus and of other newborn animals known to be sensitive to sarcoma induction by RSV or RSV tumor cells. Such animals include hamsters, rabbits, guinea pigs, and rats (1, 57, 74) . Preliminary results indicate that the src recombinant virus induces sarcomas and splenomegaly in newborn mice.
The reasons behind the different pathological picture observed in this study as compared with that in previous studies is not immediately obvious. The sarcomas observed in previous studies represent the clonal outgrowth of nonproductively transformed mammalian cells which do not produce infectious virus. In our study, the src recombinant virus is able to replicate and spread through the host animals; thus, the response observed is polyclonal in nature. Our results, therefore, may reflect what target cell is easiest for the src gene to transform in mice. This approach differs significantly from those of earlier studies which asked what cells nonreplicating RSV could transform to yield a tumor.
The results described here with the src recombinant virus may be similar to that described for the myeloproliferative sarcoma virus which induces erythroid and myeloid proliferation, formation of splenic foci, splenic foci, and splenomegaly in adult mice (29, 32, 35, 42) , although it causes sarcomas in newborn mice (14, 29) . It is interesting to note that the myeloproliferative sarcoma virus was derived from Moloney sarcoma virus by forced passage in adult BALB/c mice and that it apparently contains all of the mos gene sequence and no additional cellular sequences that are not present in Moloney sarcoma virus (46) . It is tempting to speculate that the difference in the pathological picture produced by these two closely related viruses, Moloney sarcoma virus and myeloproliferative sarcoma virus, might be due to differences in the LTRs of these two viruses.
The results of this study suggest that retroviral onc genes may not be as specific as has often been thought. In this respect, it is interesting to note that, in several cases, single retroviral onc genes transform cells in several unrelated tissue types. For example, the ras gene of Harvey, Kirsten, and Balb sarcoma viruses can induce erythroleukemia in mice (53) , despite the fact that all three viruses were isolated from sarcomas in mice or rats (28, 31, 44) . In vitro, these viruses transform mouse fibroblasts, erythroid cells (27) , and early pre-B lymphoid progenitor cells (45) . Similar findings have been noted for Abelson murine leukemia virus, which transforms lymphoid cells (49) , mouse fibroblasts (53a), and erythroid precursors present in fetal liver cells (70) .
Further experiments are under way to examine the effects of the src recombinant viruses in other mammalian species. We also hope to establish pseudotypes of the src recombinant virus which are infectious for chicken cells to determine whether the src recombinant viruses are still able to induce sarcomas in chickens. We 
